Literature DB >> 2230904

Combination therapy in systemic mycosis.

A Polak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2230904     DOI： 10.1080/1120009x.1990.11739020

Source DB:  PubMed          Journal:  J Chemother        ISSN： 1120-009X            Impact factor:   1.714


× No keyword cloud information.
  5 in total

1.  Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.

Authors:  V N Tariq; E M Scott; N E McCain
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

2.  In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans.

Authors:  N X Chin; I Weitzman; P Della-Latta
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

3.  'Primary cutaneous mucormycosis during induction chemotherapy in a child with acute lymphoblastic leukemia'.

Authors:  Jhuma Sankar; Sasi Arun; Mari Jeeva Sankar; Rachna Seth; Vasantha Thavraj; Sushil Kumar Kabra; M Vasantha
Journal:  Indian J Pediatr       Date:  2010-01-14       Impact factor: 1.967

4.  Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro.

Authors:  E M Scott; V N Tariq; R M McCrory
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

5.  Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients.

Authors:  P E Verweij; J P Donnelly; B J Kullberg; J F Meis; B E De Pauw
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.